Literature DB >> 1389485

The assessment of sexual function in cancer patients.

A M Cull1.   

Abstract

The sexual function of cancer patients may be compromised by their disease or treatment. This is infrequently assessed as an outcome variable and methodological differences between reported studies make comparison difficult. Where sexual function is being assessed as one dimension of a more comprehensive assessment of quality of life, a single item concerned with frequency of intercourse or satisfaction may be sufficient, but many studies require more detailed information. Methods developed for clinical assessment of sexual dysfunction are generally too long and detailed for this purpose. The best developed scales for cancer patients are embedded in lengthy and expensive questionnaires. A pool of items can be identified from which a scale could be derived to assess the relevant aspects of sexual experience. The development of an appropriate and psychometrically sound scale is now required to encourage greater consideration of the impact of disease and treatment on cancer patients' sexual function.

Entities:  

Mesh:

Year:  1992        PMID: 1389485     DOI: 10.1016/0959-8049(92)90068-d

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

Review 1.  Prevalence of and recent developments in female sexual dysfunction.

Authors:  R Shabsigh
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

2.  Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer.

Authors:  Jessica P Gopie; Marc A M Mureau; Caroline Seynaeve; Moniek M Ter Kuile; Marian B E Menke-Pluymers; Reinier Timman; Aad Tibben
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

3.  Psychometric properties of the Chinese version of Sexual Function After Gynecologic Illness Scale (SFAGIS).

Authors:  Ka Ming Chow; C W H Chan; K C Choi; A T Y Shiu; K K F Cheng; W Y Ip; C M W Wong
Journal:  Support Care Cancer       Date:  2013-07-05       Impact factor: 3.603

4.  A prospective comparison of quality of life measures for patients with esophageal cancer.

Authors:  Jane M Blazeby; Vasia Kavadas; Craig W Vickery; Rosemary Greenwood; Richard G Berrisford; Derek Alderson
Journal:  Qual Life Res       Date:  2005-03       Impact factor: 4.147

5.  A self-report-based study of the incidence and associations of sexual dysfunction in survivors of intensive care treatment.

Authors:  John Griffiths; Melanie Gager; Nicola Alder; Derek Fawcett; Carl Waldmann; Jane Quinlan
Journal:  Intensive Care Med       Date:  2006-02-16       Impact factor: 17.440

6.  Do male esophageal cancer patients have impaired sexual function after esophagectomy? A self-reported outcomes study.

Authors:  Xun Cao; Jiu-Di Zhong; Tian-Zhen Yang; Yu-Chuan Jiang; Zhe-Sheng Wen
Journal:  Qual Life Res       Date:  2017-08-01       Impact factor: 4.147

Review 7.  Initial report of the cancer Patient-Reported Outcomes Measurement Information System (PROMIS) sexual function committee: review of sexual function measures and domains used in oncology.

Authors:  Diana D Jeffery; Janice P Tzeng; Francis J Keefe; Laura S Porter; Elizabeth A Hahn; Kathryn E Flynn; Bryce B Reeve; Kevin P Weinfurt
Journal:  Cancer       Date:  2009-03-15       Impact factor: 6.860

8.  A mixed methods approach to adapting health-related quality of life measures for use in routine oncology clinical practice.

Authors:  Clare Harley; Elena Takeuchi; Sally Taylor; Ada Keding; Kate Absolom; Julia Brown; Galina Velikova
Journal:  Qual Life Res       Date:  2011-08-06       Impact factor: 4.147

Review 9.  Screening for sexual dysfunction in women diagnosed with breast cancer: systematic review and recommendations.

Authors:  Iris Bartula; Kerry A Sherman
Journal:  Breast Cancer Res Treat       Date:  2013-09-08       Impact factor: 4.872

10.  Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.

Authors:  Anne Sophie Oberguggenberger; Eva Nagele; Elisabeth C Inwald; Krzysztof Tomaszewski; Anne Lanceley; Andy Nordin; Carien L Creutzberg; Karin Kuljanic; Dimitrios Kardamakis; Claudia Schmalz; Juan Arraras; Anna Costantini; Thierry Almont; Chie Wei-Chu; Sara Dehandschutter; Zoe Winters; Elfriede Greimel
Journal:  Cancer Med       Date:  2018-02-13       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.